Early ultrafiltration in patients with decompensated heart failure and diuretic resistance

被引:175
作者
Costanzo, MR
Saltzberg, M
O'Sullivan, J
Sobotka, P
机构
[1] Midw Heart Fdn, Lombard, IL USA
[2] CHF Solut, Brooklyn Pk, MN USA
关键词
D O I
10.1016/j.jacc.2005.05.099
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We sought to determine if ultrafiltration before intravenous (IV) diuretics in patients with decompensated heart failure and diuretic resistance results in euvolemia and early discharge without hypotension or worsening renal function. BACKGROUND Heart failure patients with renal insufficiency and diuretic resistance have increased hospital mortality and length of stay. Peripheral veno-venous ultrafiltration may re-establish euvolemia and diuretic responsiveness. METHODS Ultrafiltration was initiated within 4.7 +/- 3.5 h of hospitalization and before IV diuretics in 20 heart failure patients with volume overload and diuretic resistance (age 74.5 +/- 8.2 years; 75% ischemic disease; ejection fraction 31 +/- 15%) and continued until euvolemia. Re-evaluation was each hospital day, at 30 days, and at 90 days. RESULTS A total of 8,654 +/- 4,205 ml were removed With ultrafiltration. Twelve patients (60%) were discharged in :53 days. One patient was readmitted in 30 days. Weight (p = 0.006), Minnesota Living with Heart Failure scores (p = 0.003), and Global Assessment (p = 0.00003) improved after ultrafiltration and at 30 and 90 days. Median B-type natriuretic peptide levels decreased after ultrafiltration (from 1,230 pg/ml to 788 pg/ml) and at 30 days (815 pg/ml) (p = 0.035). Blood pressure, renal function, and medications were unchanged. CONCLUSIONS In heart failure patients with volume overload and diuretic resistance, ultrafiltration before IV diuretics effectively and safely decreases length of stay and readmissions. Clinical benefits persist at three months.
引用
收藏
页码:2047 / 2051
页数:5
相关论文
共 15 条
  • [1] Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
    Adams, KF
    Fonarow, GC
    Emerman, CL
    LeJemtel, TH
    Costanzo, MR
    Abraham, WT
    Berkowitz, RL
    Galvao, M
    Horton, DP
    [J]. AMERICAN HEART JOURNAL, 2005, 149 (02) : 209 - 216
  • [2] SUSTAINED IMPROVEMENT IN FUNCTIONAL-CAPACITY AFTER REMOVAL OF BODY-FLUID WITH ISOLATED ULTRAFILTRATION IN CHRONIC CARDIAC-INSUFFICIENCY - FAILURE OF FUROSEMIDE TO PROVIDE THE SAME RESULT
    AGOSTONI, P
    MARENZI, G
    LAURI, G
    PEREGO, G
    SCHIANNI, M
    SGANZERLA, P
    GUAZZI, MD
    [J]. AMERICAN JOURNAL OF MEDICINE, 1994, 96 (03) : 191 - 199
  • [3] Relationship between heart failure treatment and development of worsening renal function among hospitalized patients
    Butler, J
    Forman, DE
    Abraham, WT
    Gottlieb, SS
    Loh, E
    Massie, BM
    O'Connor, CM
    Rich, MW
    Stevenson, LW
    Wang, YF
    Young, JB
    Krumholz, HM
    [J]. AMERICAN HEART JOURNAL, 2004, 147 (02) : 331 - 338
  • [4] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [5] Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting
    Dao, Q
    Krishnaswamy, P
    Kazanegra, R
    Harrison, A
    Amirnovin, R
    Lenert, L
    Clopton, P
    Alberto, J
    Hlavin, P
    Maisel, AS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 379 - 385
  • [6] Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD)
    Domanski, M
    Norman, J
    Pitt, B
    Haigney, M
    Hanlon, S
    Peyster, E
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (04) : 705 - 708
  • [7] Diuretic therapy and resistance in congestive heart failure
    Ellison, DH
    [J]. CARDIOLOGY, 2001, 96 (3-4) : 132 - 143
  • [8] COMPARISON OF NEUROENDOCRINE ACTIVATION IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION WITH AND WITHOUT CONGESTIVE-HEART-FAILURE - A SUBSTUDY OF THE STUDIES OF LEFT-VENTRICULAR DYSFUNCTION (SOLVD)
    FRANCIS, GS
    BENEDICT, C
    JOHNSTONE, DE
    KIRLIN, PC
    NICKLAS, J
    LIANG, CS
    KUBO, SH
    RUDINTORETSKY, E
    YUSUF, S
    [J]. CIRCULATION, 1990, 82 (05) : 1724 - 1729
  • [9] BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy
    Gottlieb, SS
    Brater, DC
    Thomas, I
    Havranek, E
    Bourge, R
    Goldman, S
    Dyer, F
    Gomez, M
    Bennett, D
    Ticho, B
    Beckman, E
    Abraham, WT
    [J]. CIRCULATION, 2002, 105 (11) : 1348 - 1353
  • [10] Renal function, neurohormonal activation, and survival in patients with chronic heart failure
    Hillege, HL
    Girbes, ARJ
    de Kam, PJ
    Boomsma, F
    de Zeeuw, D
    Charlesworth, A
    Hampton, JR
    van Veldhuisen, DJ
    [J]. CIRCULATION, 2000, 102 (02) : 203 - +